InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,301.57
(
0.64%
)
US TECH 100
18,356.60
(
1.16%
)
Dow Jones
39,136.71
(
0.18%
)
Brent Oil
81.73
(
0.51%
)
Bitcoin
68,190.28
(
0.39%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

micanwait

Send PM Follow Ignore
Followers 6
Posts 718
Boards Moderated 0
Alias Born 06/22/2011

micanwait

Re: None

Monday, 08/25/2014 9:52:17 AM

Monday, August 25, 2014 9:52:17 AM

Post# of 80490
Roche paid $8.3B in cash for InterMune. ITMN has an early stage pipeline in pulmonology and fibrotic diseases. Their lead drug has been approved in EU and Canada and had $35M in sales in the recent quarter. Their NDA for the US has not been filed yet with the FDA.

Valuations can be all over the place in biotech.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up